BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 7536056)

  • 1. Use of nitric oxide synthase inhibitors as a novel treatment for septic shock.
    Wolfe TA; Dasta JF
    Ann Pharmacother; 1995 Jan; 29(1):36-46. PubMed ID: 7536056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock.
    Petros A; Bennett D; Vallance P
    Lancet; 1991 Dec 21-28; 338(8782-8783):1557-8. PubMed ID: 1720856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a nitric oxide synthase inhibitor in humans with septic shock.
    Petros A; Lamb G; Leone A; Moncada S; Bennett D; Vallance P
    Cardiovasc Res; 1994 Jan; 28(1):34-9. PubMed ID: 7509259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N omega-amino-L-arginine, an inhibitor of nitric oxide synthase, raises vascular resistance but increases mortality rates in awake canines challenged with endotoxin.
    Cobb JP; Natanson C; Hoffman WD; Lodato RF; Banks S; Koev CA; Solomon MA; Elin RJ; Hosseini JM; Danner RL
    J Exp Med; 1992 Oct; 176(4):1175-82. PubMed ID: 1383377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of refractory hypotension in septic shock by inhibitor of nitric oxide synthase.
    Lin PJ; Chang CH; Chang JP
    Chest; 1994 Aug; 106(2):626-9. PubMed ID: 7539733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitric oxide synthase inhibition does not prevent cardiac depression in endotoxic shock.
    Klabunde RE; Coston AF
    Shock; 1995 Jan; 3(1):73-8. PubMed ID: 7531606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overproduction of nitric oxide in cytokine-mediated and septic shock.
    Kilbourn RG; Griffith OW
    J Natl Cancer Inst; 1992 Jun; 84(11):827-31. PubMed ID: 1375655
    [No Abstract]   [Full Text] [Related]  

  • 8. [Nitric oxide and sepsis].
    Gómez Jiménez J; Salgado Remigio A
    Med Clin (Barc); 1993 Dec; 101(19):741-2. PubMed ID: 7507194
    [No Abstract]   [Full Text] [Related]  

  • 9. NG-methyl-L-arginine, an inhibitor of nitric oxide formation, acts synergistically with dobutamine to improve cardiovascular performance in endotoxemic dogs.
    Kilbourn RG; Cromeens DM; Chelly FD; Griffith OW
    Crit Care Med; 1994 Nov; 22(11):1835-40. PubMed ID: 7956289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of endotoxin-mediated shock by NG-methyl-L-arginine, an inhibitor of nitric oxide synthesis.
    Kilbourn RG; Jubran A; Gross SS; Griffith OW; Levi R; Adams J; Lodato RF
    Biochem Biophys Res Commun; 1990 Nov; 172(3):1132-8. PubMed ID: 2244897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial nitric oxide synthase participates in septic shock myocardial depression by nitric oxide overproduction and mitochondrial permeability transition pore opening.
    Xu C; Yi C; Wang H; Bruce IC; Xia Q
    Shock; 2012 Jan; 37(1):110-5. PubMed ID: 21993446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endotoxin-induced myocardial dysfunction: is there a role for nitric oxide?
    Keller RS; Jones JJ; Kim KF; Myers PR; Adams HR; Parker JL; Rubin LJ
    Shock; 1995 Nov; 4(5):338-44. PubMed ID: 8595520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue oxygenation and hemodynamic response to NO synthase inhibition in septic shock.
    Broccard A; Hurni JM; Eckert P; Liaudet L; Schaller MD; Lazor R; Perret C; Feihl F
    Shock; 2000 Jul; 14(1):35-40. PubMed ID: 10909891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of nitric oxide synthesis in septic shock: how much is beneficial?
    Nava E; Palmer RM; Moncada S
    Lancet; 1991 Dec 21-28; 338(8782-8783):1555-7. PubMed ID: 1683974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of nitric oxide synthase--potential for a novel class of therapeutic agent?
    Ogden JE; Moore PK
    Trends Biotechnol; 1995 Feb; 13(2):70-8. PubMed ID: 7535060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitric oxide mediates the vascular actions of cytokines in septic shock.
    Smith RE; Radomski MW; Moncada S
    Eur J Clin Invest; 1992 Jun; 22(6):438-9. PubMed ID: 1378789
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of NG-nitro-L-arginine on shock induced by endotoxin and by platelet activating factor in dogs.
    Takekoshi K; Kasai K; Suzuki Y; Sekiguchi Y; Banba N; Nakamura T; Shimoda S
    Eur J Pharmacol; 1993 Dec; 250(3):465-7. PubMed ID: 7509287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of inhibition of nitric oxide synthase in acute renal failure due to endotoxin shock in dogs.
    Papadimitriou M; Economidou D; Vakianis P; Raidis C; Vrettos M; Margari P; Leontsini M
    Nephrol Dial Transplant; 1994; 9 Suppl 4():82-7. PubMed ID: 7528366
    [No Abstract]   [Full Text] [Related]  

  • 19. Attenuation of some signs of opioid withdrawal by inhibitors of nitric oxide synthase.
    Kimes AS; Vaupel DB; London ED
    Psychopharmacology (Berl); 1993; 112(4):521-4. PubMed ID: 7532866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new approach in the treatment of hypotension in human septic shock by NG-monomethyl-L-arginine, an inhibitor of the nitric oxide synthetase.
    Schilling J; Cakmakci M; Bättig U; Geroulanos S
    Intensive Care Med; 1993; 19(4):227-31. PubMed ID: 7690053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.